# Vertex Pharmaceuticals revenue entity: /record/vertex-pharmaceuticals.md predicate: revenue page: /record/vertex-pharmaceuticals/revenue as_of: 2026-11-10 cite: AsOf. "Vertex Pharmaceuticals quarterly revenue: 3,440,800,000 United States dollar", as of 2026-09-30. Claim clm_30E62BBC7C14, https://asof.is/claim/clm_30E62BBC7C14, accessed 2026-11-10. Source: https://www.sec.gov/Archives/edgar/data/875320/000087532026000291/0000875320-26-000291-index.htm. As of November 10, 2026, the latest revenue figure on the AsOf record for Vertex Pharmaceuticals is $3.44 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). Vertex Pharmaceuticals's latest full-year revenue is $12 billion, dated December 31, 2025, from a primary source (sec.gov); the two periods are kept apart, never compared. 18 claims on Vertex Pharmaceuticals's revenue, 1 open and 17 superseded, each dated and sourced; a replaced value is closed with an end date, never deleted. ## Latest revenue The newest figure for a shorter period, the quarter ended September 30, 2026: a quarterly_revenue claim, kept apart from the full-year series. Every quarterly revenue figure: /record/vertex-pharmaceuticals/quarterly_revenue.md - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | quarterly_revenue | 3,440,800,000 United States dollar | valid 2026-09-30 to present | conf 0.95 | valid | [clm_30E62BBC7C14](/claim/clm_30E62BBC7C14.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532026000291/0000875320-26-000291-index.htm ## Latest full-year revenue What the record asserts on 2026-11-10. - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 12,001,300,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_B151EC07FDAE](/claim/clm_B151EC07FDAE.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/0000875320-26-000056-index.htm ## Every dated value One claim per line, oldest first. Superseded claims stay visible. - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 175,504,000 United States dollar | valid 2008-12-31 to 2009-12-31 | conf 0.95 | superseded | superseded_by [clm_72998EF97E5B](/claim/clm_72998EF97E5B.md) | [clm_3F47912035B4](/claim/clm_3F47912035B4.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000104746911001025/0001047469-11-001025-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 101,889,000 United States dollar | valid 2009-12-31 to 2010-12-31 | conf 0.95 | superseded | superseded_by [clm_A50C566EACEB](/claim/clm_A50C566EACEB.md) | [clm_72998EF97E5B](/claim/clm_72998EF97E5B.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000104746911001025/0001047469-11-001025-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 143,370,000 United States dollar | valid 2010-12-31 to 2011-12-31 | conf 0.95 | superseded | superseded_by [clm_EDAEC8A3D536](/claim/clm_EDAEC8A3D536.md) | [clm_A50C566EACEB](/claim/clm_A50C566EACEB.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000104746911001025/0001047469-11-001025-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 1,410,626,000 United States dollar | valid 2011-12-31 to 2012-12-31 | conf 0.95 | superseded | superseded_by [clm_1A11D785AD34](/claim/clm_1A11D785AD34.md) | [clm_EDAEC8A3D536](/claim/clm_EDAEC8A3D536.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000104746912001298/0001047469-12-001298-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 1,527,042,000 United States dollar | valid 2012-12-31 to 2013-12-31 | conf 0.95 | superseded | superseded_by [clm_B995587F5A51](/claim/clm_B995587F5A51.md) | [clm_1A11D785AD34](/claim/clm_1A11D785AD34.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532013000009/0000875320-13-000009-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 1,211,975,000 United States dollar | valid 2013-12-31 to 2014-12-31 | conf 0.95 | superseded | superseded_by [clm_76E972477DD6](/claim/clm_76E972477DD6.md) | [clm_B995587F5A51](/claim/clm_B995587F5A51.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532014000015/0000875320-14-000015-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 580,415,000 United States dollar | valid 2014-12-31 to 2015-12-31 | conf 0.95 | superseded | superseded_by [clm_B9A0D3A94E4B](/claim/clm_B9A0D3A94E4B.md) | [clm_76E972477DD6](/claim/clm_76E972477DD6.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532015000012/0000875320-15-000012-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 1,032,336,000 United States dollar | valid 2015-12-31 to 2016-12-31 | conf 0.95 | superseded | superseded_by [clm_3048F4177FBD](/claim/clm_3048F4177FBD.md) | [clm_B9A0D3A94E4B](/claim/clm_B9A0D3A94E4B.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532016000067/0000875320-16-000067-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 1,702,177,000 United States dollar | valid 2016-12-31 to 2017-12-31 | conf 0.95 | superseded | superseded_by [clm_88AABB0F5900](/claim/clm_88AABB0F5900.md) | [clm_3048F4177FBD](/claim/clm_3048F4177FBD.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532017000017/0000875320-17-000017-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 2,488,652,000 United States dollar | valid 2017-12-31 to 2018-12-31 | conf 0.95 | superseded | superseded_by [clm_9652C550528A](/claim/clm_9652C550528A.md) | [clm_88AABB0F5900](/claim/clm_88AABB0F5900.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532018000009/0000875320-18-000009-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 3,047,597,000 United States dollar | valid 2018-12-31 to 2019-12-31 | conf 0.95 | superseded | superseded_by [clm_98E5E59F6D9E](/claim/clm_98E5E59F6D9E.md) | [clm_9652C550528A](/claim/clm_9652C550528A.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532019000006/0000875320-19-000006-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 4,162,821,000 United States dollar | valid 2019-12-31 to 2020-12-31 | conf 0.95 | superseded | superseded_by [clm_710D5BB40195](/claim/clm_710D5BB40195.md) | [clm_98E5E59F6D9E](/claim/clm_98E5E59F6D9E.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532020000007/0000875320-20-000007-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 6,205,683,000 United States dollar | valid 2020-12-31 to 2021-12-31 | conf 0.95 | superseded | superseded_by [clm_054958897891](/claim/clm_054958897891.md) | [clm_710D5BB40195](/claim/clm_710D5BB40195.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532021000006/0000875320-21-000006-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 7,574,400,000 United States dollar | valid 2021-12-31 to 2022-12-31 | conf 0.95 | superseded | superseded_by [clm_AC7CF3A293FF](/claim/clm_AC7CF3A293FF.md) | [clm_054958897891](/claim/clm_054958897891.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532022000007/0000875320-22-000007-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 8,930,700,000 United States dollar | valid 2022-12-31 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_6755CB60586A](/claim/clm_6755CB60586A.md) | [clm_AC7CF3A293FF](/claim/clm_AC7CF3A293FF.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532023000007/0000875320-23-000007-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 9,869,200,000 United States dollar | valid 2023-12-31 to 2024-12-31 | conf 0.95 | superseded | superseded_by [clm_9011721F7C0D](/claim/clm_9011721F7C0D.md) | [clm_6755CB60586A](/claim/clm_6755CB60586A.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532024000062/0000875320-24-000062-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 11,020,100,000 United States dollar | valid 2024-12-31 to 2025-12-31 | conf 0.95 | superseded | superseded_by [clm_B151EC07FDAE](/claim/clm_B151EC07FDAE.md) | [clm_9011721F7C0D](/claim/clm_9011721F7C0D.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532025000053/0000875320-25-000053-index.htm - [Vertex Pharmaceuticals](/record/vertex-pharmaceuticals.md) | revenue | 12,001,300,000 United States dollar | valid 2025-12-31 to present | conf 0.95 | valid | [clm_B151EC07FDAE](/claim/clm_B151EC07FDAE.md) sources: https://www.sec.gov/Archives/edgar/data/875320/000087532026000056/0000875320-26-000056-index.htm ## What replaced what - $175.5 million (2008-12-31 to 2009-12-31, [clm_3F47912035B4](/claim/clm_3F47912035B4.md)) was replaced by $101.89 million from 2009-12-31 ([clm_72998EF97E5B](/claim/clm_72998EF97E5B.md)) - $101.89 million (2009-12-31 to 2010-12-31, [clm_72998EF97E5B](/claim/clm_72998EF97E5B.md)) was replaced by $143.37 million from 2010-12-31 ([clm_A50C566EACEB](/claim/clm_A50C566EACEB.md)) - $143.37 million (2010-12-31 to 2011-12-31, [clm_A50C566EACEB](/claim/clm_A50C566EACEB.md)) was replaced by $1.41 billion from 2011-12-31 ([clm_EDAEC8A3D536](/claim/clm_EDAEC8A3D536.md)) - $1.41 billion (2011-12-31 to 2012-12-31, [clm_EDAEC8A3D536](/claim/clm_EDAEC8A3D536.md)) was replaced by $1.53 billion from 2012-12-31 ([clm_1A11D785AD34](/claim/clm_1A11D785AD34.md)) - $1.53 billion (2012-12-31 to 2013-12-31, [clm_1A11D785AD34](/claim/clm_1A11D785AD34.md)) was replaced by $1.21 billion from 2013-12-31 ([clm_B995587F5A51](/claim/clm_B995587F5A51.md)) - $1.21 billion (2013-12-31 to 2014-12-31, [clm_B995587F5A51](/claim/clm_B995587F5A51.md)) was replaced by $580.42 million from 2014-12-31 ([clm_76E972477DD6](/claim/clm_76E972477DD6.md)) - $580.42 million (2014-12-31 to 2015-12-31, [clm_76E972477DD6](/claim/clm_76E972477DD6.md)) was replaced by $1.03 billion from 2015-12-31 ([clm_B9A0D3A94E4B](/claim/clm_B9A0D3A94E4B.md)) - $1.03 billion (2015-12-31 to 2016-12-31, [clm_B9A0D3A94E4B](/claim/clm_B9A0D3A94E4B.md)) was replaced by $1.7 billion from 2016-12-31 ([clm_3048F4177FBD](/claim/clm_3048F4177FBD.md)) - $1.7 billion (2016-12-31 to 2017-12-31, [clm_3048F4177FBD](/claim/clm_3048F4177FBD.md)) was replaced by $2.49 billion from 2017-12-31 ([clm_88AABB0F5900](/claim/clm_88AABB0F5900.md)) - $2.49 billion (2017-12-31 to 2018-12-31, [clm_88AABB0F5900](/claim/clm_88AABB0F5900.md)) was replaced by $3.05 billion from 2018-12-31 ([clm_9652C550528A](/claim/clm_9652C550528A.md)) - $3.05 billion (2018-12-31 to 2019-12-31, [clm_9652C550528A](/claim/clm_9652C550528A.md)) was replaced by $4.16 billion from 2019-12-31 ([clm_98E5E59F6D9E](/claim/clm_98E5E59F6D9E.md)) - $4.16 billion (2019-12-31 to 2020-12-31, [clm_98E5E59F6D9E](/claim/clm_98E5E59F6D9E.md)) was replaced by $6.21 billion from 2020-12-31 ([clm_710D5BB40195](/claim/clm_710D5BB40195.md)) - $6.21 billion (2020-12-31 to 2021-12-31, [clm_710D5BB40195](/claim/clm_710D5BB40195.md)) was replaced by $7.57 billion from 2021-12-31 ([clm_054958897891](/claim/clm_054958897891.md)) - $7.57 billion (2021-12-31 to 2022-12-31, [clm_054958897891](/claim/clm_054958897891.md)) was replaced by $8.93 billion from 2022-12-31 ([clm_AC7CF3A293FF](/claim/clm_AC7CF3A293FF.md)) - $8.93 billion (2022-12-31 to 2023-12-31, [clm_AC7CF3A293FF](/claim/clm_AC7CF3A293FF.md)) was replaced by $9.87 billion from 2023-12-31 ([clm_6755CB60586A](/claim/clm_6755CB60586A.md)) - $9.87 billion (2023-12-31 to 2024-12-31, [clm_6755CB60586A](/claim/clm_6755CB60586A.md)) was replaced by $11.02 billion from 2024-12-31 ([clm_9011721F7C0D](/claim/clm_9011721F7C0D.md)) - $11.02 billion (2024-12-31 to 2025-12-31, [clm_9011721F7C0D](/claim/clm_9011721F7C0D.md)) was replaced by $12 billion from 2025-12-31 ([clm_B151EC07FDAE](/claim/clm_B151EC07FDAE.md)) ## Questions this record answers ### What is Vertex Pharmaceuticals's current revenue? The latest figure on the record is $3.44 billion for the quarter ended September 30, 2026, from a primary source (sec.gov). The latest full-year figure is $12 billion, dated December 31, 2025, from a primary source (sec.gov). The record asserts both as of November 10, 2026. ### What was Vertex Pharmaceuticals's revenue for the quarter ended September 30, 2026? $3.44 billion for the quarter ended September 30, 2026, dated September 30, 2026, from a primary source (sec.gov) (status valid, confidence 0.95). ### When did Vertex Pharmaceuticals's revenue last change? The latest value on the record is $12 billion, dated December 31, 2025; before it the record holds $11.02 billion, dated December 31, 2024 and closed on December 31, 2025. ### What was Vertex Pharmaceuticals's revenue before $12 billion? $11.02 billion, valid from December 31, 2024 to December 31, 2025 (status superseded), from a primary source (sec.gov). ## Read on - This page: /record/vertex-pharmaceuticals/revenue (markdown: /record/vertex-pharmaceuticals/revenue.md) - Entity twin: /record/vertex-pharmaceuticals.md ยท timeline: /timelines/vertex-pharmaceuticals.md - Every company's revenue: /facts/revenue.md --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.